Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinase type 1: Implications for diabetic nephropathy

Endocrinology

Volumn 145, Issue 12, 2004, Pages 5646-5655

  McLennan, S V ^a,b   Wang, X Y ^b   Moreno, V ^a   Yue, D K ^a,b   Twigg, S M ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; GELATINASE A; GLUCOSE; MATRIX METALLOPROTEINASE; MESSENGER RNA; NEUTRALIZING ANTIBODY; RECOMBINANT GROWTH FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEGRADATION; DIABETIC NEPHROPATHY; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; GLOMERULUS; HUMAN; HUMAN CELL; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT;

ANIMALS; ANTIBODIES; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; GLOMERULAR MESANGIUM; GLUCOSE; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; RATS; RATS, INBRED WF; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA;

EID: 9444265403     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-0436     Document Type: Article

References (51)

1. Ayo SH, Radnik RA, Garoni JA, Glass 2nd WF, Kreisberg JI 1990 High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am J Pathol [Erratum (1990) 137:preceding 225] 136:1339-1348
2. Kreisberg JI, Garoni JA, Radnik R, Ayo SH 1994 High glucose and TGF/β1 stimulate fibronectin gene expression through a cAMP response element. Kidney Int 46:1019-1024
3. Nakamura T, Fukui M, Ebihara I, Osada S, Tomino Y, Koide H 1994 Abnormal gene expression of matrix metalloproteinases and their inhibitors in glomeruli from diabetic rats. Renal Physiol Biochem 17:316-325
4. Abdel Wahab N, Mason RM 1996 Modulation of neutral protease expression in human mesangial cells by hyperglycaemic culture. Biochem J 320:777-783
5. McLennan SV, Yue DK, Turtle JR 1998 Effect of glucose on matrix metalloproteinase activity in mesangial cells. Nephron 79:293-298
6. McLennan SV, Fisher EJ, Yue DK, Turtle JR 1994 High glucose concentration causes a decrease in mesangium degradation: a factor in the pathogenesis of diabetic nephropathy. Diabetes 43:1041-1045
7. Murphy G, Docherty AJ 1992 The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol 7:120-125
8. Lehti K, Valtanen H, Wickstrom S, Lohi J, Keski-Oja J 2000 Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain. J Biol Chem 275:15006-15013
9. Murphy G 1995 Matrix metalloproteinases and their inhibitors. Acta Orthop Scand Suppl 266:55-60
10. Imai K, Ohuchi E, Aoki T, Nomura H, Fujii Y, Sato H, Seiki M, Okada Y 1996 Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res 56:2707-2710
11. Zhao H, Bernardo M, Osenkowski P, Sohail A, Pei D, Nagase H, Kashiwagi M 2004 Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 regulates pro-MMP-2 activation. J Biol Chem 279:8592-8601
12. Shankland SJ, Ly H, Thai K, Scholey JW 1996 Glomerular expression of tissue inhibitor of metalloproteinase (TIMP-1) in normal and diabetic rats. J Am Soc Nephrol 7:97-104
13. Moussad EE, Brigstock DR 2000 Connective tissue growth factor: what's in a name? Mol Genet Metab 71:276-292
14. Igarashi A, Okochi H, Bradham DM, Grotendorst GR 1993 Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 4:637-645
15. Frazier K, Williams S, Kothapalli D, Klapper H, Grotendorst GR 1996 Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 107:404-411
16. Twigg SM, Chen MM, Joly AH, Chakrapani SD, Tsubaki J, Kim HS, Oh Y, Rosenfeld RG 2001 Advanced glycosylation end products up-regulate connective tissue growth factor (insulin-like growth factor-binding protein-related protein 2) in human fibroblasts: a potential mechanism for expansion of extracellular matrix in diabetes mellitus. Endocrinology 142:1760-1769
17. Ito Y, Aten J, Bende RJ, Oemar BS, Rabelink TJ, Weening JJ, Goldschmeding R 1998 Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 53:853-861
18. Igarashi A, Hayashi N, Nashiro K, Takehara K 1998 Differential expression of connective tissue growth factor gene in cutaneous fibrohistiocytic and vascular tumors. J Cutan Pathol 25:143-148
19. Way KJ, Isshiki K, Suzuma K, Yokota T, Zvagelsky D, Schoen FJ, Sandusky GE, Pechous PA, Vlahos CJ, Wakasaki H, King GL 2002 Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase Cβ2 activation and diabetes. Diabetes 51:2709-2718
20. Dammeier J, Brauchte M, Falk W, Grotendorst GR, Werner S 1998 Connective tissue growth factor: a novel regulator of mucosal repair and fibrosis in inflammatory bowel disease? Int J Biochem Cell Biol 30:909-922
21. Igarashi A, Nashiro K, Kikuchi K, Sato S, Ihn H, Fujimoto M, Grotendorst GR, Takehara K 1996 Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J Invest Dermatol 106:729-733
22. Candido R, Jandeleit-Dahm KA, Cao Z, Nesteroff SP, Burns WC, Twigg SM, Dilley RJ, Cooper ME, Allen TJ 2002 Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice. Circulation 106:246-253
23. Adler SG, Kang SW, Feld S, Cha DR, Barba L, Striker L, Striker G, Riser BL, LaPage J, Nast CC 2001 Glomerular mRNAs in human type 1 diabetes: biochemical evidence for microalbuminuria as a manifestation of diabetic nephropathy. Kidney Int [Erratum (2002) 61:1197] 60:2330-2336
24. Riser BL, Denichilo M, Cortes P, Baker C, Grondin JM, Yee J, Narins RG 2000 Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol 11:25-38
25. Murphy M, Godson C, Cannon S, Kato S, Mackenzie HS, Martin F, Brady HR 1999 Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem 274:5830-5834
26. He TC, Zhou S, Costa LTD, Yu J, Kinzler KW, Vogelstein B 1998 A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95:2509-2514
27. Kim HS, Nagalla SR, Oh Y, Wilson E, Roberts Jr CT, Rosenfeld RG 1997 Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily. Proc Natl Acad Sci USA 94:12981-12986
28. Twigg SM, Joly AH, Chen MM, Tsubaki J, Kim HS, Hwa V, Oh Y, Rosenfeld RG 2002 Connective tissue growth factor/IGF-binding protein-related protein-2 is a mediator in the induction of fibronectin by advanced glycosylation end-products in human dermal fibroblasts. Endocrinology 143:1260-1269
29. Yang DH, Kim HS, Wilson EM, Rosenfeld RG, Oh Y 1998 Identification of glycosylated 38-kDa connective tissue growth factor (IGFBP-related protein 2) and proteolytic fragments in human biological fluids, and up-regulation of IGFBP-rP2 expression by TGF-β in Hs578T human breast cancer cells. J Clin Endocrinol Metab 83:2593-2596
30. Twigg SM, Cao Z, SV MC, Burns WC, Brammar G, Forbes JM, Cooper ME 2002 Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine. Endocrinology 143:4907-4915
31. Pfaffl MW 2001 A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:2003-2007
32. McLennan SV, Martell SK, Yue DK 2002 Effects of mesangium glycation on matrix metalloproteinase activities: possible role in diabetic nephropathy. Diabetes 51:2612-2618
33. McLennan SV, Kelly DJ, Cox AJ, Cao Z, Lyons JG, Yue DK, Gilbert RE 2002 Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases. Diabetologia 45:268-275
34. Hattori S, Fujisaki H, Kiriyama T, Yokoyama T, Irie S 2002 Real-time zymography and reverse zymography: a method for detecting activities of matrix metalloproteinases and their inhibitors using FITC-labelled collagen and casein as substrates. Anal Biochem 301:27-34
35. McLennan SV, Martell SY, Yue DK 2000 High glucose concentration inhibits the expression of membrane type metalloproteinase by mesangial cells: possible role in mesangium accumulation. Diabetologia 43:642-648
36. Mori T, Kawara S, Shinozaki M, Hayashi N, Kakinuma T, Igarashi A, Takigawa M, Nakanishi T, Takehara K 1999 Role and interaction of connective tissue growth factor with transforming growth factor-β in persistent fibrosis: a mouse fibrosis model. J Cell Physiol 181:153-159
37. Border WA, Noble NA 1997 TGF-β in kidney fibrosis: a target for gene therapy. Kidney Int 51:1388-1396
38. Mauer SM, Lane P, Zhu D, Fioretto P, Steffes MW 1992 Renal structure and function in insulin-dependent diabetes mellitus in man. J Hypertens Suppl 10:S17-S20
39. Shimo T, Nakanishi T, Nishida T, Asano M, Kanyama M, Kuboki T, Tamatani T, Tezuka K, Takemura M, Matsumura T, Takigawa M 1999 Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. J Biochem 126:137-145
40. Brigstock DR 2002 Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61). Angiogenesis 5:153-165
41. Lam S, van der Geest RN, Verhagen NA, van Nieuwenhoven FA, Blom IE, Aten J, Goldschmeding R, Daha MR, van Kooten C 2003 Connective tissue growth factor and IGF-I are produced by human renal fibroblasts and cooperate in the induction of collagen production by high glucose. Diabetes 2975-2983
42. Fan WH, Karnovsky MJ 2002 Increased MMP-2 expression in connective tissue growth factor over-expression vascular smooth muscle cells. J Biol Chem 277:9800-9805
43. Hishikawa K, Oemar BS, Tanner FC, Nakaki T, Luscher TF, Fujii T 1999 Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7. J Biol Chem 274:37461-37466
44. Matrisian LM, Hogan BL 1990 Growth factor-regulated proteases and extracellular matrix remodeling during mammalian development. Curr Top Dev Biol 24:219-259
45. Gupta S, Clarkson MR, Duggan J, Brady HR 2000 Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis. Kidney Int 58:1389-1399
46. Yokoi H, Sugawara A, Mukoyama M, Mori K, Makino H, Suganami T, Nagae T, Yahata K, Fujinaga Y, Tanaka I, Nakao K 2001 Role of connective tissue growth factor in profibrotic action of transforming growth factor-β: a potential target for preventing renal fibrosis. Am J Kidney Dis 38:S134-S138
47. Abreu JG, Ketpura NI, Reversade B, De Robertis EM 2002 Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-β. Nat Cell Biol 4:599-604
48. Kondo S, Kubota S, Shimo T, Nishida T, Yosimichi G, Eguchi T, Sugahara T, Takigawa M 2002 Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases. Carcinogenesis 23:769-776
49. Wang JF, Olson ME, Ball DK, Brigstock DR, Hart DA 2003 Recombinant connective tissue growth factor modulates porcine skin fibroblast gene expression. Wound Repair Regen 11:220-229
50. Kanemoto K, Usui J, Tomari S, Yokoi H, Mukoyama M, Aten J, Weening JJ, Nagata M 2003 Connective tissue growth factor participates in scar formation of crescentic glomerulonephrins. Lab Invest 83:1615-1625
51. Hashimoto G, Inoki I, Fujii Y, Aoki T, Ikeda E, Okada Y 2002 Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. J Biol Chem 277:36288-36295